As of November 2024, Biotechnology Assets has a market cap of $19.66M. This makes Biotechnology Assets the world's 30160th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $25.08M | -1.26% |
2023 | $25.40M | 72.17% |
2022 | $14.75M | -49.89% |
2021 | $29.44M | -17.45% |
2020 | $35.66M | -72.75% |
2019 | $130.83M | 22.16% |
2018 | $107.10M | -43.96% |
2017 | $191.11M | -4.18% |
2016 | $199.45M | -59.03% |
2015 | $486.75M | -3.92% |
2014 | $506.63M | 66.32% |
2013 | $304.62M | 110.18% |
2012 | $144.94M | - |